ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

DCE Board Approves Recompetitions, Program Announcement For Research On Fish

July 7, 1989

Group Backing Epstein Received Grants From Reynolds Foundation

May 15, 1992

DCBDC To Contract For CA Agents In Vaccine Testing

November 15, 1991

Reexamine Mandates, Samuels Suggests

February 17, 1984

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990